Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A comparison of multiple patient reported outcome measures in identifying major depressive disorder in people with multiple sclerosis.
TRPM2 Cation Channels Modulate T Cell Effector Functions and Contribute to Autoimmune CNS Inflammation.
A pilot study of a telehealth intervention for persons with spinal cord dysfunction.
Walking while talking in patients with multiple sclerosis: The impact of specific cognitive loads.
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid and the diagnosis of multiple sclerosis.
Managed care aspects of managing multiple sclerosis.
TREK-King the Blood-Brain-Barrier.
The relationship between cognitive function and high-resolution diffusion tensor MRI of the cingulum bundle in multiple sclerosis.
Cognitive impairment in MS: Impact of white matter integrity, gray matter volume, and lesions.
Acute optic neuritis: Unmet clinical needs and model for new therapies.
Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3T.
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort.
Interlukin-18 Is a Pivot Regulatory Factor on Matrix Metalloproteinase-13 Expression and Brain Astrocytic Migration.
Alternative data sources for estimating multiple sclerosis prevalence.
SLAM-SAP Signaling Promotes Differentiation of IL-17-Producing T Cells and Progression of Experimental Autoimmune Encephalomyelitis.
Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression.
Status migrainosus as an initial presentation of multiple sclerosis.
Translation and Cultural Adaptation of the Multidimensional Scale of Perceived Social Support for Greece.
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?
What is the true clinicopathologic spectrum of neuromyelitis optica?-Reply.
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
Time-efficient, high-resolution, whole brain three-dimensional macromolecular proton fraction mapping.
Concurrent acute disseminated encephalomyelitis and Guillain-Barré syndrome in a child.
Pages
« first
‹ previous
…
382
383
384
385
386
387
388
389
390
…
next ›
last »